Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial

Fig. 2

Oxygen uptake pre-dose and post-dose for patients after administration of (a) BUD/FORM and (b) placebo.*,†. BUD/FORM, budesonide/formoterol; CI, confidence interval; LS, least squares; VO2, oxygen uptake. *Each line represents an individual patient and treatment. In each panel, the pair of data points with error bars are LS mean (95% CI) values at pre-dose and post-dose

Back to article page